Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
Objectives: To evaluate the safety and effectiveness of cell therapy using Precision Cell Immunotherapy to treat Advanced Gastric Cancer. Eligibility: Individuals greater than or equal to 18 years of age and less than or equal to 65 years of age who have been diagnosed with Advanced Gastric Cancer.
Epistemonikos ID: acca75c5163103ef430806af70076fe3e87bc8a8
First added on: May 17, 2024